Gainers Aclarion (NASDAQ:ACON) stock moved upwards by 28.8% to $11.08 during Friday’s after-market session. The market value of their outstanding shares is at $4.9 million. Spyre Therapeutics (NASDAQ:SYRE) stock rose 13.2% to $21.64. The company’s market cap stands at $1.2 billion. Inventiva (NASDAQ:IVA) stock moved upwards by 7.47% to $4.89. The company’s market cap stands at $769.1 million. Immatics (NASDAQ:IMTX) stock increased by 6.17% to $11.0. The market value of their outstanding shares is at $1.3 billion. Nanobiotix (NASDAQ:NBTX) shares moved upwards by 5.93% to $25.0. The company’s market cap stands at $1.4 billion. Gelteq (NASDAQ:GELS) stock increased by 5.38% to $1.37. The market value of their outstanding shares is at $13.6 million. Losers Quoin Pharmaceuticals (NASDAQ:QNRX) stock declined by 21.7% to $16.06 during Friday’s after-market session. The market value of their outstanding shares is at $4.7 million. CARISMA Therapeutics (NASDAQ:CARM) shares decreased by 14.17% to $0.13. The market value of their outstanding shares is at $11.4 million. Hyperion DeFi (NASDAQ:HYPD) stock fell 10.34% to $7.2. The market value of their outstanding shares is at $82.8 million. cbdMD (AMEX:YCBD) shares decreased by 8.14% to $1.13. The market value of their outstanding shares is at $12.9 million. Shuttle Pharmaceuticals (NASDAQ:SHPH) stock declined by 7.81% to $3.78. The company’s market cap stands at $5.0 million. I-MAB (NASDAQ:IMAB) stock fell 7.76% to $4.4. The company’s market cap stands at $559.0 million. See Also: http://www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
ACONAclarion Inc$11.3935.1%OverviewCARMCARISMA Therapeutics Inc$0.1219-55.5%GELSGelteq Ltd$1.370.74%HYPDHyperion DeFi Inc$7.88-6.08%IMABI-MAB$4.40-9.28%IMTXImmatics NV$11.000.92%IVAInventiva SA$4.89-11.6%NBTXNanobiotix SA$25.00-16.4%QNRXQuoin Pharmaceuticals Ltd$16.97108.0%SHPHShuttle Pharmaceuticals Holdings Inc$3.78-20.6%SYRESpyre Therapeutics Inc$21.642.22%YCBDcbdMD Inc$1.21-16.6%Market News and Data brought to you by Benzinga APIs
